CEO Chris Viehbacher talks ‘old Sanofi,’ ‘new Sanofi,’ and pharma’s future in Boston
Boston Business Journal by Julie M. Donnelly, Reporter
Date: Thursday, April 12, 2012, 3:08pm EDT – Last Modified: Friday, April 13, 2012, 12:35pm EDT
Viehbacher said he believes Sanofi should take on new disease areas like Alzheimer’s, re-commit itself to tackling cardiovascular disease, and stay away from developing depression drugs.
www.bizjournals.com/boston/news/2012/04/12/sanofi-ceo-chris-viehbacher.html?ana=lnk
2012pharmaceutical
Amandeep Kaur
Aashir Awan, Phd
Abhisar Anand
Adina Hazan
Alan F. Kaul, PharmD., MS, MBA, FCCP
alexcrystal6
anamikasarkar
apreconasia
aviralvatsa
David Orchard-Webb, PhD
danutdaagmailcom
Demet Sag, Ph.D., CRA, GCP
Dror Nir
dsmolyar
Ethan Coomber
evelinacohn
Gail S Thornton
Irina Robu
jayzmit48
jdpmd
jshertok
kellyperlman
Ed Kislauskis
larryhbern
Madison Davis
marzankhan
megbaker58
ofermar2020
Dr. Pati
pkandala
ritusaxena
Rick Mandahl
sjwilliamspa
Srinivas Sriram
stuartlpbi
Dr. Sudipta Saha
tildabarliya
vaishnavee24
zraviv06
zs22
Leave a Reply